Antiphospholipid Antibodies: An Under-Recognized Cause of Morbidity and Mortality in Patients Transplanted for End Stage Liver Disease

被引：0
|
作者：
Villamil, A. [1 ]
Bandi, J. C. [1 ]
Galdame, O. [1 ]
Carballo, G. [2 ]
de Santibanes, E. [1 ]
Gadano, A. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Liver Transplantat Unit, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Immunoserol Sect, Buenos Aires, DF, Argentina
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00416
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
2153
引用
收藏
页码：223 / 223
页数：1
相关论文
共 50 条
  • [31] Advances in lymphedema: An under-recognized disease with a hopeful future for patients
    Carroll, Brett J.
    Singhal, Dhruv
    VASCULAR MEDICINE, 2024, 29 (01) : 70 - 84
  • [32] Antiphospholipid (aPL) antibodies in end-stage renal disease
    Fabrizi, F
    Sangiorgio, R
    Pontoriero, G
    Corti, M
    Tentori, F
    Troina, E
    Locatelli, F
    JOURNAL OF NEPHROLOGY, 1999, 12 (02) : 89 - 94
  • [33] Nodular regenerative hyperplasia of the liver: An under-recognized cause of portal hypertension in hematological disorders
    Al-Mukhaizeem, KA
    Rosenberg, A
    Sherker, AH
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 75 (04) : 225 - 230
  • [34] Acute thyroiditis: An under-recognized complication of parathyroidectomy in end-stage renal failure patients with secondary hyperparathyroidism
    Chan, Gary C. W.
    Lee, Paul C. H.
    Kwan, Lorraine P. Y.
    Yip, Terence P. S.
    Tang, Sydney C. W.
    NEPHROLOGY, 2017, 22 (07) : 572 - 572
  • [35] Cause of postoperative mortality in patients with end-stage renal disease
    Song, Sanghoon
    Cho, Chaeyeon
    Park, Sun Young
    Cho, Ho Bum
    Yoo, Jae Hwa
    Kim, Mun Gyu
    Chung, Ji Won
    Kim, Sang Ho
    ANESTHESIA AND PAIN MEDICINE, 2022, 17 (02):
  • [36] Surgical mortality and morbidity in patients with end-stage renal disease (ESRD).
    Chertow, GM
    Henderson, W
    Khuri, S
    Hur, K
    Daley, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0639 - A0639
  • [37] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [38] Inflammatory Bowel Disease in Patients with Chronic Granulomatous Disease May Be Under-Recognized
    Benson, Brenna
    Shyr, David
    Guthery, Stephen
    Chen, Karin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 143 (02) : AB111 - AB111
  • [39] Osteoporosis: an under-recognized risk for early-stage multiple sclerosis patients?
    Holmoy, Trygve
    FUTURE NEUROLOGY, 2011, 6 (06) : 723 - 726
  • [40] Liver Disease as a Risk Factor for Cognitive Decline and Dementia: an Under-Recognized Issue
    Yilmaz, Yusuf
    Ozdogan, Osman
    HEPATOLOGY, 2009, 49 (02) : 698 - 698
12345